Immunogenicity and tolerability of a multicomponent meningococcal serogroup B (4CMenB) vaccine in healthy adolescents in Chile: a phase 2b/3 randomised, observer-blind, placebo-controlled study (Q56706209)
scientific article published on January 18, 2012
Language:
(P31) (Q13442814)
(P50) (Q91463200)
(P304) 617-624
(P407) (Q1860)
(P433) 9816
(P478) 379
(P577) Wednesday, January 18, 2012
(P921) (Q269829)
(Q1492760)
(Q134808)
(Q298)
(P953) https://api.elsevier.com/content/article/PII:S0140673611617133?httpAccept=text/xml
https://api.elsevier.com/content/article/PII:S0140673611617133?httpAccept=text/plain
(P1433) (Q939416)
(P1476) "Immunogenicity and tolerability of a multicomponent meningococcal serogroup B (4CMenB) vaccine in healthy adolescents in Chile: a phase 2b/3 randomised, observer-blind, placebo-controlled study" (language: en)
(P2093) María Elena Santolaya
María Teresa Valenzuela
Valeria Prado
Rodrigo Vergara
Alma Muñoz
Gabriela Graña
Huajun Wang
Ralf Clemens
V72P10 Meningococcal B Adolescent Vaccine Study group
Miguel L. O'Ryan
Peter M. Dull
(P2860) (Q44677055)
(Q37735610)
(Q36711456)
(Q38381404)
(Q83106446)
(Q33610843)
(Q54484873)
(Q48907979)
(Q37683962)
(Q33646965)
(Q33892877)
(Q36101910)
(Q33734798)
(Q64901018)
(Q34739055)
(Q54329423)
(Q37492987)
(Q34320259)
(Q34039044)
(Q60213378)
(Q84554545)
(Q80694408)
(Q58493020)
other details
description scientific article published on January 18, 2012

External Links